The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to the use of amoebae or their environmentally stable spores to control agricultural infections and other uses.

The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to the use of amoebae or their environmentally stable spores to control agricultural infections and other uses.

Compositions are provided that contain biologically active components of amniotic fluid including growth factors and other proteins, carbohydrates, lipids, and metabolites. The compositions containing biologically active components of amniotic fluid can be useful for a range of therapeutic treatments including joint and soft tissue repair, regulation of skin condition, and for use in organ preservation, such as for use in organ transplant procedures. Advantages of the compositions include that they can be reproducibly produced, without the inherent variability of amniotic fluid from individual donors, and that they are free of fetal waste.

Compositions are provided that contain biologically active components of amniotic fluid including growth factors and other proteins, carbohydrates, lipids, and metabolites. The compositions containing biologically active components of amniotic fluid can be useful for a range of therapeutic treatments including joint and soft tissue repair, regulation of skin condition, and for use in organ preservation, such as for use in organ transplant procedures. Advantages of the compositions include that they can be reproducibly produced, without the inherent variability of amniotic fluid from individual donors, and that they are free of fetal waste.

Compositions are provided that contain biologically active components of amniotic fluid including growth factors and other proteins, carbohydrates, lipids, and metabolites. The compositions containing biologically active components of amniotic fluid can be useful for a range of therapeutic treatments including joint and soft tissue repair, regulation of skin condition, and for use in organ preservation, such as for use in organ transplant procedures. Advantages of the compositions include that they can be reproducibly produced, without the inherent variability of amniotic fluid from individual donors, and that they are free of fetal waste.

Provided herein are compositions, systems, and methods for suppressing a population of insects such as flies. Some embodiments relate to compositions comprising a fermented biomass, a dye and a particulate matter. Some embodiments relate to systems and methods for use of the compositions described herein. The compositions are biodegradable, non-toxic, and environmentally friendly.

Provided herein are compositions, systems, and methods for suppressing a population of insects such as flies. Some embodiments relate to compositions comprising a fermented biomass, a dye and a particulate matter. Some embodiments relate to systems and methods for use of the compositions described herein. The compositions are biodegradable, non-toxic, and environmentally friendly.

A method for mosquito control is provided in the form of mosquito larvicide carrying insects which can be introduced in a mosquito population to thereby control the mosquito population. The larvicide carrier insects may include artificially generated adult insect carriers of a mosquito larvicide in which the mosquito larvicide has minimal impact on the adult insect carrier and which mosquito larvicide affects juvenile mosquito survival or interferes with metamorphosis of juvenile mosquitoes to adulthood. The larvicide carrier insects may be either male or female and may include mosquitoes and non-mosquito insects.

A method for mosquito control is provided in the form of mosquito larvicide carrying insects which can be introduced in a mosquito population to thereby control the mosquito population. The larvicide carrier insects may include artificially generated adult insect carriers of a mosquito larvicide in which the mosquito larvicide has minimal impact on the adult insect carrier and which mosquito larvicide affects juvenile mosquito survival or interferes with metamorphosis of juvenile mosquitoes to adulthood. The larvicide carrier insects may be either male or female and may include mosquitoes and non-mosquito insects.

Signal sequences useful for targeting proteins and peptides to the surface of endospores produced by Paenibacillus family members and methods of using the same are provided. The display of heterologous molecules, such as peptides, polypeptides and other recombinant constructs, on the spore surface of Paenibacillus family members, using particular N-terminal targeting sequences and derivatives of the same, are also provided.